DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
CD40 LIGAND
2
Unknown
Investigational
Unknown
Unknown
Melanoma
Tumor necrosis factor receptor superfamily member 5 agonist
CD40 LIGAND
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BGT-226
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Hamartoma Syndrome, Multiple; Neoplasms
PI3-kinase class I inhibitor
BGT-226
×
Maximum Phase:
2
First Approval:
None
UNII:
ZXE7F2GMJJ
Molecule Type:
Small molecule
Molecular Formula:
C28H25F3N6O2
Molecular Weight:
534.54
AlogP:
4.38
PSA:
77.21
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LEFITOLIMOD
2
Unknown
Investigational
Unknown
Unknown
HIV Infections
Toll-like receptor 9 agonist
LEFITOLIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
6SO72A12FN
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
STRONTIUM-89
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
STRONTIUM-89
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SQUARIC ACID DIBUTYL ESTER
2
Small molecule
Investigational
Unknown
Unknown
Herpes Labialis
Unknown
SQUARIC ACID DIBUTYL ESTER
×
Maximum Phase:
2
First Approval:
None
UNII:
4RTO57VG65
Molecule Type:
Small molecule
Molecular Formula:
C12H18O4
Molecular Weight:
226.27
AlogP:
1.64
PSA:
52.6
HBD:
0.0
HBA:
#RotB:
8.0
Source:
ELEZANUMAB
2
Antibody
Investigational
Unknown
Unknown
Ischemic Stroke; Multiple Sclerosis; Spinal Cord Injuries
Repulsive guidance molecule A inhibitor
ELEZANUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
SK1LVT23A1
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ORG-34517
2
Small molecule
Investigational
Unknown
Unknown
Alcoholism; Depressive Disorder; Depressive Disorder, Major
Glucocorticoid receptor antagonist
ORG-34517
×
Maximum Phase:
2
First Approval:
None
UNII:
17VAN37K4Y
Molecule Type:
Small molecule
Molecular Formula:
C28H30O4
Molecular Weight:
430.54
AlogP:
5.07
PSA:
55.76
HBD:
1.0
HBA:
#RotB:
1.0
Source:
IODOCARB
2
Small molecule
Investigational
Unknown
Unknown
Fatigue Syndrome, Chronic; Pulmonary Disease, Chronic Obstructive
Unknown
IODOCARB
×
Maximum Phase:
2
First Approval:
None
UNII:
603P14DHEB
Molecule Type:
Small molecule
Molecular Formula:
C8H12INO2
Molecular Weight:
281.09
AlogP:
1.91
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ENMD-2076
2
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms; Multiple Myeloma; Neoplasms; Adenocarcinoma, Clear Cell; Breast Neoplasms; Carcinoma, Hepatocellular; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Sarcoma
Fibroblast growth factor receptor 3 inhibitor
ENMD-2076
×
Maximum Phase:
2
First Approval:
None
UNII:
J6U9WP10T7
Molecule Type:
Small molecule
Molecular Formula:
C21H25N7
Molecular Weight:
375.48
AlogP:
3.17
PSA:
72.97
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BLU-5937
2
Unknown
Investigational
Unknown
Unknown
Cough
Unknown
BLU-5937
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AR-67
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Gliosarcoma; Myelodysplastic Syndromes
Unknown
AR-67
×
Maximum Phase:
2
First Approval:
None
UNII:
3YEA04NV6H
Molecule Type:
Small molecule
Molecular Formula:
C26H30N2O5Si
Molecular Weight:
478.62
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
VELUSETRAG
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Gastroparesis
Serotonin 4 (5-HT4) receptor agonist
VELUSETRAG
×
Maximum Phase:
2
First Approval:
None
UNII:
J4VNV64ARB
Molecule Type:
Small molecule
Molecular Formula:
C25H36N4O5S
Molecular Weight:
504.65
AlogP:
1.56
PSA:
111.95
HBD:
2.0
HBA:
#RotB:
8.0
Source:
DE-112
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DE-112
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AEZS-108
2
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
AEZS-108
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IRL790
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IRL790
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EVENAMIDE
2
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Sodium channel alpha subunit blocker
EVENAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
ON5S6N53JS
Molecule Type:
Small molecule
Molecular Formula:
C16H26N2O2
Molecular Weight:
278.4
AlogP:
2.09
PSA:
41.57
HBD:
1.0
HBA:
#RotB:
9.0
Source:
GS-0938
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GS-0938
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLOROPHENYLPIPERAZINE
2
Small molecule
Investigational
Unknown
Unknown
Alcoholism; Cocaine-Related Disorders
Unknown
CHLOROPHENYLPIPERAZINE
×
Maximum Phase:
2
First Approval:
None
UNII:
REY0CNO998
Molecule Type:
Small molecule
Molecular Formula:
C10H13ClN2
Molecular Weight:
196.68
AlogP:
1.75
PSA:
15.27
HBD:
1.0
HBA:
#RotB:
1.0
Source:
VELAFERMIN
2
Protein
Investigational
Unknown
Unknown
Stomatitis
Unknown
VELAFERMIN
×
Maximum Phase:
2
First Approval:
None
UNII:
6Z25C35927
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARTEROLANE
2
Small molecule
Investigational
Unknown
Unknown
Malaria, Falciparum
Unknown
ARTEROLANE
×
Maximum Phase:
2
First Approval:
None
UNII:
3N1TN351VB
Molecule Type:
Small molecule
Molecular Formula:
C29H44N2O7S
Molecular Weight:
564.75
AlogP:
3.25
PSA:
82.81
HBD:
2.0
HBA:
#RotB:
4.0
Source:
REGRELOR
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
REGRELOR
×
Maximum Phase:
2
First Approval:
None
UNII:
Q6C8TY6SW1
Molecule Type:
Small molecule
Molecular Formula:
C22H25N6O8P
Molecular Weight:
532.45
AlogP:
1.8
PSA:
179.18
HBD:
4.0
HBA:
#RotB:
8.0
Source:
E-7090
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Liver Diseases; Cholangiocarcinoma; Neoplasms
Fibroblast growth factor receptor 1 inhibitor
E-7090
×
Maximum Phase:
2
First Approval:
None
UNII:
TN7CUD1NGA
Molecule Type:
Small molecule
Molecular Formula:
C32H37N5O6
Molecular Weight:
587.68
AlogP:
4.47
PSA:
127.18
HBD:
3.0
HBA:
#RotB:
11.0
Source:
RAMATERCEPT
2
Protein
Investigational
Unknown
Unknown
Muscular Diseases; Muscular Dystrophy, Duchenne
Growth/differentiation factor 8 inhibitor
RAMATERCEPT
×
Maximum Phase:
2
First Approval:
None
UNII:
42HQC6QLEK
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATRELEUTON
2
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome; Atherosclerosis; Coronary Disease
Arachidonate 5-lipoxygenase inhibitor
ATRELEUTON
×
Maximum Phase:
2
First Approval:
None
UNII:
U301T88E1M
Molecule Type:
Small molecule
Molecular Formula:
C16H15FN2O2S
Molecular Weight:
318.37
AlogP:
2.99
PSA:
66.56
HBD:
2.0
HBA:
#RotB:
3.0
Source:
AZTREONAM LYSINE
2
Small molecule
Investigational
Unknown
Unknown
Bronchiectasis
Unknown
AZTREONAM LYSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
XNM7LT65NP
Molecule Type:
Small molecule
Molecular Formula:
C19H31N7O10S2
Molecular Weight:
581.63
AlogP:
-1.17
PSA:
201.58
HBD:
4.0
HBA:
#RotB:
7.0
Source:
REVUSIRAN
2
Oligonucleotide
Investigational
Unknown
Unknown
Amyloid Neuropathies, Familial
Transthyretin mRNA RNAi inhibitor
REVUSIRAN
×
Maximum Phase:
2
First Approval:
None
UNII:
ZE6EHM8Z3A
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GI-6207
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GI-6207
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACETOSIDE
2
Oligosaccharide
Investigational
Unknown
Unknown
Glomerulonephritis, IGA
Unknown
ACETOSIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
3TGX09BD5B
Molecule Type:
Oligosaccharide
Molecular Formula:
C29H36O15
Molecular Weight:
624.59
AlogP:
-1.02
PSA:
245.29
HBD:
9.0
HBA:
#RotB:
10.0
Source:
KN-026
2
Unknown
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms
Unknown
KN-026
×
Maximum Phase:
2
First Approval:
None
UNII:
RHS90QRF9E
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FERROUS ASCORBATE
3
Small molecule
Investigational
Unknown
Unknown
Anemia
Unknown
FERROUS ASCORBATE
×
Maximum Phase:
3
First Approval:
None
UNII:
DI3477D0PI
Molecule Type:
Small molecule
Molecular Formula:
C12H14FeO12
Molecular Weight:
406.08
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MELARSOPROL
3
Small molecule
Investigational
Unknown
Unknown
Leishmaniasis; Trypanosomiasis
Unknown
MELARSOPROL
×
Maximum Phase:
3
First Approval:
None
UNII:
ZF3786Q2E8
Molecule Type:
Small molecule
Molecular Formula:
C12H15AsN6OS2
Molecular Weight:
398.35
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TABALUMAB
3
Antibody
Investigational
Unknown
Unknown
Multiple Myeloma; Multiple Sclerosis, Relapsing-Remitting; Renal Insufficiency, Chronic; Arthritis, Rheumatoid; Lupus Erythematosus, Systemic
Tumor necrosis factor ligand superfamily member 13B inhibitor
TABALUMAB
×
Maximum Phase:
3
First Approval:
None
UNII:
PQP8VH3MJW
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AGAR
3
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AGAR
×
Maximum Phase:
3
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEGESTROL
3
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MEGESTROL
×
Maximum Phase:
3
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYTISINICLINE
3
Small molecule
Investigational
Unknown
Unknown
Smoking Cessation; Tobacco Use Disorder
Neuronal acetylcholine receptor; alpha4/beta2 partial agonist
CYTISINICLINE
×
Maximum Phase:
3
First Approval:
None
UNII:
53S5U404NU
Molecule Type:
Small molecule
Molecular Formula:
C11H14N2O
Molecular Weight:
190.25
AlogP:
0.55
PSA:
34.03
HBD:
1.0
HBA:
#RotB:
0.0
Source:
1
2
…
202
203
204
205
206
207
208
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA